Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_assertion type Assertion NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_head.
- NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_assertion description "[Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_provenance.
- NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_assertion evidence source_evidence_literature NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_provenance.
- NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_assertion SIO_000772 18448549 NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_provenance.
- NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_assertion wasDerivedFrom befree-2016 NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_provenance.
- NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_assertion wasGeneratedBy ECO_0000203 NP668691.RAV9kb0pJooxhbJtnx35vDQOd_bPSY3hvJcNIvOQttBZc130_provenance.